flow trial semaglutide kidney outcomes 2024 nejm hazard ratio Long-term of in obesity and cardiovascular disease in the SELECT Effects of semaglutide with and – Semaglutide in patients with overweight – significant 24% reduction in kidney

Stewart, S.A

Many users report improved mood and mental clarity during month one

Liver function improvements occur as fatty liver resolves, something you might feel as increased energy before it shows on any scale

Semaxen (Semaglutide), generic OZEMPIC is a prescription medicine used to treat type 2 diabetes mellitus with improving glycemic control in patients and to reduce the risk of major adverse cardiovascular events in patients with type 2 diabetes mellitus and established cardiovascular disease

Other adherence studies suggest oral semaglutide can perform similarly to established oral therapies and, in some groups, may show better persistence than injectable semaglutide over 12 months (source)